Mesalamine and dehydration Patient Reports February 11, 2012

Mesalamine Side Effects Report #6003673-5
Mesalamine side effect was reported by a Physician from DENMARK on Dec 08, 2008. Male patient, 66 years of age, was diagnosed with colitis collagenous and was treated with Mesalamine. After drug was administered, patient experienced the following side effects: dehydration, pyrexia. Mesalamine dosage: unknown. During the same period patient was treated with SIMVASTATIN, MAGNYL, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.

Mesalamine Side Effects Report #6103140-4
Mesalamine side effect was reported by a Physician from DENMARK on Feb 25, 2009. Male patient, 66 years of age, was diagnosed with colitis collagenous and was treated with Mesalamine. After drug was administered, patient experienced the following side effects: dehydration, electrolyte imbalance, infection , pyrexia. Mesalamine dosage: unknown. During the same period patient was treated with SIMVASTATIN, MAGNYL, BISOPROLOL. Patient was hospitalized. Patient recovered.

Mesalamine Side Effects Report #4562719-1
Mesalamine side effect was reported by a Consumer or non-health professional from on Jan 11, 2005. Female patient, 23 years of age, was treated with Mesalamine. After drug was administered, patient experienced the following side effects: condition aggravated, dehydration, eosinophilia, food allergy , gastritis erosive, gastroenteritis eosinophilic, lymphocyte transformation test positive, proctitis. Mesalamine dosage: unknown. During the same period patient was treated with PANTOPRAZOLE. Patient recovered.

Mesalamine Side Effects Report #5528399-3
Mesalamine side effect was reported by a Physician from UNITED KINGDOM on Nov 07, 2007. Female patient, 13 years of age, was treated with Mesalamine. After drug was administered, patient experienced the following side effects: crohn's disease , dehydration, haemodialysis, haemoglobin decreased, nephritis interstitial, renal cortical necrosis, renal failure acute, renal infarct, renal tubular necrosis. Mesalamine dosage: unknown. During the same period patient was treated with DICLOFENAC, CEFOTAXIME, HYDROCORTISONE, METRONIDAZOLE. Patient was hospitalized. Patient recovered.